Logo

POCI

Precision Optics Corporation, Inc.

POCI

Precision Optics Corporation, Inc. • NASDAQ
$4.56 ▼ -1.72% (-0.08)
Market Cap $35.18 M
52w High $5.48
52w Low $3.77
Dividend Yield 0%
P/E -5.36
Volume 12.56K
Outstanding Shares 7.71M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q1-2026 $6.681M ▲ $2.542M ▲ $-1.637M ▼ -24.503% ▼ $-0.21 ▼ $-1.53M ▼
Q4-2025 $6.181M ▲ $2.155M ▼ $-1.403M ▲ -22.69% ▲ $-0.19 ▲ $-1.303M ▲
Q3-2025 $4.186M ▼ $2.456M ▲ $-2.097M ▼ -50.09% ▼ $-0.3 ▼ $-1.976M ▼
Q2-2025 $4.527M ▲ $1.98M ▼ $-969.681K ▲ -21.42% ▲ $-0.15 ▲ $-860.825K ▲
Q1-2025 $4.197M $2.364M $-1.311M -31.242% $-0.21 $-1.199M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q1-2026 $1.392M ▼ $22.385M ▲ $11.461M ▲ $10.923M ▼
Q4-2025 $1.774M ▼ $19.79M ▲ $7.531M ▲ $12.259M ▼
Q3-2025 $2.548M ▲ $19.622M ▲ $6.445M ▼ $13.178M ▲
Q2-2025 $212.441K ▼ $17.511M ▲ $8.035M ▲ $9.476M ▼
Q1-2025 $635.572K $17.239M $7.101M $10.137M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2026 $-1.637M ▼ $78.227K ▲ $-301.789K ▼ $-158.068K ▼ $-381.63K ▲ $-226.504K ▲
Q4-2025 $-1.403M ▲ $-569.235K ▲ $-83.636K ▲ $-121.267K ▼ $-774.138K ▼ $-615.459K ▲
Q3-2025 $-2.097M ▼ $-1.873M ▼ $-89.752K ▼ $4.298M ▲ $2.335M ▲ $-1.997M ▼
Q2-2025 $-969.681K ▲ $-786.809K ▼ $-31.986K ▼ $395.664K ▼ $-423.131K ▼ $-818.795K ▼
Q1-2025 $-1.311M $-318.622K $-28.099K $577.015K $230.294K $-342.971K

Revenue by Products

Product Q1-2025Q2-2025Q4-2025Q1-2026
Engineering Design Services
Engineering Design Services
 $0 ▲$0 ▲$0 ▲$0 ▲
Medical Device Products And Assemblies
Medical Device Products And Assemblies
 $0 ▲$0 ▲$0 ▲$0 ▲
Optical Components
Optical Components
 $0 ▲$0 ▲$0 ▲$0 ▲

Five-Year Company Overview

Income Statement

Income Statement The company operates on a relatively small revenue base that has been fairly steady in recent years, with only gradual growth. Gross profit exists but appears thin, and the latest year shows a clear step back into operating losses after several years hovering around break-even. Net income has turned more clearly negative, with per-share losses widening, which suggests either higher costs, investment in growth, or difficulty leveraging scale. Overall, the business is not yet demonstrating consistent, durable profitability and remains sensitive to small changes in revenue or cost structure.

Balance Sheet

Balance Sheet The balance sheet looks small and simple, with a modest asset base and no meaningful reported debt, which reduces financial leverage risk. Equity is positive, but not large, pointing to a relatively thin capital cushion. Reported cash levels appear very low, which, if accurate, could indicate tight liquidity and a reliance on timely collections or external funding to support operations and growth. In short, the company is lightly levered but also not heavily capitalized, leaving limited room to absorb shocks without new capital or improved cash generation.

Cash Flow

Cash Flow Operating cash flow and free cash flow have been hovering around break-even, without clear, sustained cash generation. This pattern suggests that the business has not yet reached a point where it consistently funds itself and growth from internal cash. Capital spending appears modest, which fits a specialized, design- and engineering-heavy model rather than a heavy manufacturing footprint. The key issue is the lack of visible cash surplus: execution missteps, delays in moving programs to production, or customer timing could quickly pressure liquidity in a company of this size.

Competitive Edge

Competitive Edge Precision Optics operates in a narrow but high-value niche: extremely small, high-performance optical systems for medical, aerospace, and defense uses. Its long history, deep design expertise, and ability to handle the full lifecycle—from design through manufacturing and regulatory support—create meaningful barriers to entry. Customers in medical devices and defense tend to be sticky because switching vendors is technically difficult and regulatory-heavy, which works in the company’s favor once it is designed into a product or program. However, the customer base and program set are likely concentrated, so the loss or delay of even a few key programs could materially affect performance. The competitive position is strong in depth and specialization, but fragile in scale.

Innovation and R&D

Innovation and R&D Innovation is clearly the core of the story. The company’s proprietary micro-optics capabilities, ability to build ultra-small endoscopes and micro-camera systems, and expertise in 3D endoscopic imaging give it a distinct technical edge. Its Unity Imaging Platform aims to standardize and speed up endoscopic system development for customers, potentially improving scalability and margins if adoption grows. Expansion into aerospace borescopes and augmented reality systems for defense shows that the same core technology can open new, high-value markets. The main risk is execution: turning advanced prototypes and development contracts into stable, long-running production programs at meaningful volumes is crucial for translating innovation into financial strength.

Summary

Precision Optics is a highly specialized, innovation-driven company operating at the intersection of medical technology and defense optics. Technologically, it appears ahead of many peers in micro-optics and 3D imaging, with strong know-how, vertical integration, and sticky, high-regulation customers. Financially, however, it remains a small, vulnerable business: revenue is modest, profitability has not yet stabilized, cash generation is weak, and the balance sheet does not show a large safety buffer. The opportunity lies in scaling existing programs, successfully commercializing the Unity platform, and converting development wins in medical and defense into recurring production revenue. The key risks revolve around scale, program concentration, and liquidity: a few setbacks or delays can have an outsized impact on a company of this size, even with strong technology and a solid niche position.

NEWS

November 13, 2025 · 4:30 PM UTC

Precision Optics Reports First Quarter Fiscal Year 2026 Financial Results

Read more

November 11, 2025 · 9:00 AM UTC

Precision Optics Announces Product Development Agreement to Develop Custom High-End Borescope for Jet Engines

Read more

November 7, 2025 · 9:00 AM UTC

Precision Optics Announces Product Development Agreement to Deliver Next-Generation Augmented Reality Sub-Systems for Fighter Pilots

Read more

November 6, 2025 · 4:15 PM UTC

Precision Optics Schedules First Quarter of Fiscal Year 2026 Conference Call for November 13, 2025

Read more

September 30, 2025 · 8:00 AM UTC

Precision Optics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

Read more